Harrow: California Accusation, Settlement Could Spur Other State Boards of Pharmacy to Take Action Against ImprimisRx
Harrow (HROW), an ophthalmic drug company, announced last week that its compounding business had reached a settlement with the California Board of Pharmacy, paying a fine of $157,000 and voluntarily...
Feb 10, 2026
Read Now >


